Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, announced a new collaboration with Merck, known as MSD outside of...
Merck, known as MSD outside of the United States and Canada, announced the completion of the Prometheus Biosciences, Inc. acquisition. Prometheus is now a...
Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, announces a global research collaboration with MSD, the trade...
